Loading company…
Telomere Therapeutics develops telomerase gene therapies for pulmonary and renal fibrosis.
Telomere Therapeutics develops telomerase gene therapy to treat pulmonary fibrosis and renal fibrosis. Founded in 2020, the biotechnology company is based in Barcelona, Spain.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in